Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to understand the study and sign a consent form
- People aged 60 years or older
- People who have been diagnosed with geographic atrophy caused by age-related macular degeneration, confirmed by eye imaging
- People whose affected eye area falls within a specific size range and is clearly visible on imaging
- People whose eye condition allows for good-quality images and reliable measurements during the study
- People who have at least a minimum required level of vision in the study eye
- Women who could become pregnant must have a negative pregnancy test and agree to use effective contraception during the study (this requirement does not apply to women who have gone through menopause or have had surgery that prevents pregnancy)
Who may not be able to join:
- People who have had, or currently have, certain eye conditions in the study eye — such as fluid build-up in the retina, abnormal blood vessel growth, retinal detachment, or blood vessel blockages
- People who have previously had major eye surgery, including retinal surgery or vitrectomy (a procedure involving the gel inside the eye)
- People who have previously had laser treatment or injections in the study eye
- People who have any other eye condition that could affect vision testing, imaging, or study results
- People who have planned eye surgery during the time the study is running
- People who have recently received experimental treatments for geographic atrophy
- People who have active medical implants
- People who have serious or uncontrolled health conditions, a history of epilepsy, poor general health, or conditions that would make it difficult to follow study procedures
- People who are currently taking part in, or have recently taken part in, another clinical trial
- People who are breastfeeding, have relevant allergies (such as to silver), or smoke heavily
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Florian Gekeler, Prof. Dr., Department of Ophthalmology, Klinikum Stuttgart, Germany
Phone: +49 7121 15935
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of TES therapy in GA
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.